Myomo (MYO) EBT Margin (2016 - 2025)
Myomo posted quarterly EBT Margin of 34.96% for Q3 2025, down 2538.0% year-on-year from 1.43% in Q3 2024, and up 24.75% on a QoQ basis from 46.45% in Q2 2025.
Myomo (MYO) has 10 years of EBT Margin data on file, last reported at 34.96% in Q3 2025.
- For the quarter ending Q3 2025, EBT Margin fell 2538.0% year-over-year to 34.96%; the trailing twelve-month figure through Sep 2025 stood at 11.26% (down 1397.0% YoY), and the FY2024 full-year result was 3.09%, down 68.0% from the prior year.
- EBT Margin for Q3 2025 stood at 34.96%, up from 46.45% in the prior quarter.
- Across five years, EBT Margin topped out at 133.03% in Q4 2023 and bottomed at 125.51% in Q1 2021.
- The 5-year median for EBT Margin is 46.45% (2025), against an average of 41.55%.
- Peak annual rise in EBT Margin reached 29877 bps in 2021, while the deepest fall reached 33241 bps in 2021.
- A 5-year view of EBT Margin shows it stood at 72.48% in 2021, then grew by 19 bps to 58.68% in 2022, then surged by 327 bps to 133.03% in 2023, then tumbled by 59 bps to 55.1% in 2024, then plunged by 163 bps to 34.96% in 2025.
- The last three EBT Margin figures came in at 34.96% (Q3 2025), 46.45% (Q2 2025), and 33.85% (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.17% |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -34.96% |
| Jun 30, 2025 | -46.45% |
| Mar 31, 2025 | -33.85% |
| Dec 31, 2024 | 55.10% |
| Sep 30, 2024 | -9.57% |
| Jun 30, 2024 | -13.40% |
| Mar 31, 2024 | -99.98% |
| Dec 31, 2023 | 133.03% |
| Sep 30, 2023 | -39.03% |
| Jun 30, 2023 | -17.08% |
| Mar 31, 2023 | -75.49% |
| Dec 31, 2022 | -58.68% |
| Sep 30, 2022 | -70.72% |
| Jun 30, 2022 | -79.27% |
| Mar 31, 2022 | -70.80% |
| Dec 31, 2021 | -72.48% |
| Sep 30, 2021 | -46.40% |
| Jun 30, 2021 | -83.94% |
| Mar 31, 2021 | -125.51% |
| Dec 31, 2020 | 259.93% |
| Sep 30, 2020 | -144.05% |
| Jun 30, 2020 | -382.70% |
| Mar 31, 2020 | -377.07% |
| Dec 31, 2019 | -162.77% |
| Sep 30, 2019 | -459.62% |
| Jun 30, 2019 | -291.40% |
| Mar 31, 2019 | -312.99% |
| Dec 31, 2018 | -342.61% |
| Sep 30, 2018 | -437.31% |
| Jun 30, 2018 | -416.25% |
| Mar 31, 2018 | -753.79% |
| Dec 31, 2017 | -2,340.88% |
| Sep 30, 2017 | -302.60% |
| Jun 30, 2017 | -678.12% |
| Mar 31, 2017 | -8,278.67% |
| Dec 31, 2016 | -371.96% |
| Sep 30, 2016 | -461.14% |
| Jun 30, 2016 | -242.95% |